[go: up one dir, main page]

WO2001018030A3 - Petits peptides a forte activite anti-angiogenique - Google Patents

Petits peptides a forte activite anti-angiogenique Download PDF

Info

Publication number
WO2001018030A3
WO2001018030A3 PCT/SG2000/000131 SG0000131W WO0118030A3 WO 2001018030 A3 WO2001018030 A3 WO 2001018030A3 SG 0000131 W SG0000131 W SG 0000131W WO 0118030 A3 WO0118030 A3 WO 0118030A3
Authority
WO
WIPO (PCT)
Prior art keywords
potent anti
angiogenic activity
small peptides
peptides
prevention
Prior art date
Application number
PCT/SG2000/000131
Other languages
English (en)
Other versions
WO2001018030A2 (fr
Inventor
Rowen Ge
R Manjunatha Kini
Original Assignee
Univ Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Singapore filed Critical Univ Singapore
Publication of WO2001018030A2 publication Critical patent/WO2001018030A2/fr
Publication of WO2001018030A3 publication Critical patent/WO2001018030A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des peptides possédant une forte activité anti-angiogénique. Ces peptides peuvent être administrés sous la forme de compositions pharmaceutiques destinées à la prévention ou au traitement de l'angiogénèse non souhaitée, notamment pour prévenir la formation de métastases tumorales ou inhiber la croissance de tumeurs primaires.
PCT/SG2000/000131 1999-09-03 2000-09-01 Petits peptides a forte activite anti-angiogenique WO2001018030A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG9904310-1 1999-09-03
SG9904310A SG87828A1 (en) 1999-09-03 1999-09-03 Small peptides having potent anti-angiogenic activity

Publications (2)

Publication Number Publication Date
WO2001018030A2 WO2001018030A2 (fr) 2001-03-15
WO2001018030A3 true WO2001018030A3 (fr) 2001-09-27

Family

ID=20430423

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SG2000/000131 WO2001018030A2 (fr) 1999-09-03 2000-09-01 Petits peptides a forte activite anti-angiogenique

Country Status (2)

Country Link
SG (1) SG87828A1 (fr)
WO (1) WO2001018030A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20060625A1 (it) * 2006-03-31 2007-10-01 Istituto Naz Per La Ricerca Peptide antiangiogenico e suoi impieghi terapeutici
WO2014037332A1 (fr) * 2012-09-04 2014-03-13 Università Degli Studi Di Torino Inhibiteurs du complexe intégrine alpha6/e-cadhérine et leur utilisation thérapeutique et de diagnostic dans le cancer
AU2018326835A1 (en) * 2017-08-31 2020-03-26 National University Of Singapore Angio-3 for treatment of retinal angiogenic diseases

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997015666A1 (fr) * 1995-10-23 1997-05-01 The Children's Medical Center Corporation Compositions therapeutiques anti-angiogenese et procedes associes
WO1997041824A2 (fr) * 1996-05-03 1997-11-13 Abbott Laboratories Nouveaux peptides anti-angiogeniques, polypeptides les codant et procedes d'inhibition de l'angiogenese
WO2000026368A2 (fr) * 1998-10-30 2000-05-11 The Children's Medical Center Corporation Compositions therapeutiques d'endostatine anti-angiogenique

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997015666A1 (fr) * 1995-10-23 1997-05-01 The Children's Medical Center Corporation Compositions therapeutiques anti-angiogenese et procedes associes
WO1997041824A2 (fr) * 1996-05-03 1997-11-13 Abbott Laboratories Nouveaux peptides anti-angiogeniques, polypeptides les codant et procedes d'inhibition de l'angiogenese
US6057122A (en) * 1996-05-03 2000-05-02 Abbott Laboratories Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis
WO2000026368A2 (fr) * 1998-10-30 2000-05-11 The Children's Medical Center Corporation Compositions therapeutiques d'endostatine anti-angiogenique

Also Published As

Publication number Publication date
WO2001018030A2 (fr) 2001-03-15
SG87828A1 (en) 2002-04-16

Similar Documents

Publication Publication Date Title
WO2002080890A3 (fr) Composition pharmaceutique de jasmonate pour le traitement du cancer
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
WO2002070438A3 (fr) Compositions permettant l'administration de biophosphonates
WO2002048147A3 (fr) Composes therapeutiques
WO2001098236A3 (fr) Composes de tetracycline 7-phenyl-substituee
IL162214A0 (en) Pyridine derivatives and pharmaceutical compositions containing the same
AU3652102A (en) Compounds and their uses
MY134136A (en) Novel compounds comprising jak3 kinase inhibitors
WO2001056552A3 (fr) Inhibiteurs de la farnesyl proteine transferase pour le traitement du cancer du sein
AU2001271987A1 (en) Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species
WO2003041653A3 (fr) Agents cytotoxiques
WO1998008505A8 (fr) Composes pharmaceutiques
WO2001081316A3 (fr) Inhibiteurs de phenyle farnesyltransferase substitues
WO2003037863A3 (fr) Indoles substitues, procede pour leur preparation et leur utilisation pour lutter contre la douleur
WO2001046455A3 (fr) Stimulation de l'angiogenèse par l'utilisation de survivine
MXPA04005809A (es) Inhibidores de proteinas quinasas.
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
WO2003037912A3 (fr) Tripeptides, tetrapeptides et pentapeptides a activite anti-angiogenese
WO2003066022A3 (fr) Preparation pharmaceutique stable pour le traitement des troubles gastro-intestinaux
WO2002047604A3 (fr) Utilisation des composes de la classe des chalcones pour inhiber la vascularisation d'une masse tumorale
WO2001018030A3 (fr) Petits peptides a forte activite anti-angiogenique
MXPA04000805A (es) Peptidos que tienen actividad antiangiogenica.
WO2002020000A3 (fr) Blocage d'oestrogene du sein combine au moyen d'exemestane et de raloxifene
WO2005011725A3 (fr) Agent anti-angiogenique et son utilisation, notamment dans le cadre du traitement des cancers
AP2001002369A0 (en) Pharmaceutical complex.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CN JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): CN JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP